Urea Cycle Disorder Agents

Urea cycle disorder agents are a therapeutic class of metabolic medications primarily functioning as nitrogen-scavenging compounds or synthetic enzyme activators These agents, which include sodium phenylbutyrate, glycerol phenylbutyrate, and carglumic acid, work by providing alternative metabolic pathways for waste nitrogen excretion or by restoring critical enzymatic function to prevent the accumulation of neurotoxic ammonia They are clinically indicated for the acute management and long-term m...

Urea cycle disorder agents are a therapeutic class of metabolic medications primarily functioning as nitrogen-scavenging compounds or synthetic enzyme activators These agents, which include sodium phenylbutyrate, glycerol phenylbutyrate, and carglumic acid, work by providing alternative metabolic pathways for waste nitrogen excretion or by restoring critical enzymatic function to prevent the accumulation of neurotoxic ammonia

Urea cycle disorder agents are a therapeutic class of metabolic medications primarily functioning as nitrogen-scavenging compounds or synthetic enzyme activators

These agents, which include sodium phenylbutyrate, glycerol phenylbutyrate, and carglumic acid, work by providing alternative metabolic pathways for waste nitrogen excretion or by restoring critical enzymatic function to prevent the accumulation of neurotoxic ammonia

They are clinically indicated for the acute management and long-term maintenance of inherited urea cycle disorders—such as ornithine transcarbamylase, carbamoyl phosphate synthetase, and argininosuccinate synthetase deficiencies—typically serving as adjunctive therapy alongside dietary protein restriction to prevent hyperammonemic crises and permanent neurological damage

They are clinically indicated for the acute management and long-term maintenance of inherited urea cycle disorders—such as ornithine transcarbamylase, carbamoyl phosphate synthetase, and argininosuccinate synthetase deficiencies—typically serving as adjunctive therapy alongside dietary protein restriction to prevent hyperammonemic crises and permanent neurological damage